|
Change History |
Title |
|
To remove all references to 'Health Solutions Wales', 'Business Services Centre' and 'Information Products Unit' and replace with 'NHS Wales Informatics Service' | |
|
All Wales Lung Cancer Minimum Reporting Requirements v4.0 including Core Reporting Items v5.0 |
Data Items Lung Cancer Minimum Reporting Requirements
Summary Table of Reporting Requirements
The following tables outline the matrix of data items against reporting requirements.
ALL WALES LUNG CANCER MINIMUM REPORTING REQUIREMENT V4.0
Key: ENCDv4.5b = English National Cancer Dataset version 4.5b; matched data item
SPCDv1.0 = Specialist Palliative Care Dataset version 1.0; matched data item
NLCA = national lung cancer audit
LCI = Lung Clinical Indicator
|
Summary of Reporting Data Items: |
Minimum Reporting Requirements | ||||
|
Core |
Lung Site Specific | ||||
|
National Cancer Standards |
WCISU: Cancer Registry |
AOF: CWT |
NLCA |
Lung Clinical Indicators | |
|
Section 1: Identification of Patient | |||||
|
NHS Number |
ü |
ü |
ü |
ü |
|
|
Birth date |
ü |
ü |
|
ü |
|
|
Sex |
ü |
ü |
|
ü |
|
|
GP practice code |
ü |
ü |
|
|
|
|
Ethnic group |
ü |
ü |
|
|
|
|
Case record number |
ü |
ü |
|
|
|
|
Patient’s name(s) |
ü |
ü |
|
ü |
|
|
Patient’s address at date of diagnosis |
ü |
ü |
|
|
|
|
Patient’s postcode at date of diagnosis |
ü |
ü |
|
ü |
|
|
Section 2: Referral | |||||
|
Source of (cancer) referral |
ü |
|
|
ü |
|
|
Organisation code (referred to) |
ü |
|
|
ü |
ü |
|
Consultant code (referred to) |
ü |
|
|
|
|
|
Date of receipt of cancer referral |
ü |
|
|
|
|
|
Presentation of disease at referral |
ü |
ü |
ü |
|
ü |
|
Date of cancer referral |
|
|
|
ü |
|
|
Date first seen |
|
|
|
ü |
|
|
Section 3: Key Investigations | |||||
|
Cancer imaging modality |
ü |
ü |
|
ü |
ü |
|
Date of investigation |
ü |
ü |
|
ü |
|
|
Cancer sampling modality – Lung |
|
|
|
ü |
|
|
FEV1 (Forced Expiratory Volume in 1 second) absolute |
|
|
|
ü |
|
|
FEV1 (Forced Expiratory Volume in 1 second) percentage of predicted |
|
|
|
ü |
|
|
Section 4: Diagnosis | |||||
|
Date of diagnosis (cancer registry definition) |
ü |
ü |
|
ü |
|
|
Basis of diagnosis (cancer registry definition) |
ü |
ü |
|
ü |
|
|
Primary cancer site |
ü |
ü |
|
ü |
ü |
|
Pre-treatment morphology |
ü |
ü |
ü |
ü |
ü |
|
Pre-treatment staging agreed by the multi disciplinary team cT (clinical Tumour) stage |
ü |
ü |
|
ü |
ü |
|
Pre-treatment staging agreed by the multi disciplinary team cN (clinical Node) stage |
ü |
ü |
|
ü |
ü |
|
Pre-treatment staging agreed by the multi disciplinary team cM (clinical Metastasis) stage |
ü |
ü |
|
ü |
ü |
|
Laterality of cancer |
|
ü |
|
ü |
|
|
Final pre-treatment stage grouping |
|
ü |
|
ü |
ü |
|
Section 5: Multi Disciplinary Team Outcomes | |||||
|
Treatment plan discussed by the multi disciplinary team |
ü |
|
|
ü |
|
|
Multi disciplinary meeting identifier |
ü |
|
|
|
|
|
Date treatment plan discussed by the multi disciplinary team |
ü |
|
|
ü |
|
|
Cancer treatment plan intent |
ü |
|
|
ü |
|
|
Reason for no specific anti-cancer treatment |
ü |
|
|
|
|
|
Final pre-treatment performance status agreed by the multi disciplinary team |
ü |
ü |
|
ü |
ü |
|
Planned cancer treatment type |
ü |
|
|
ü |
|
|
Treatment type sequence |
ü |
|
|
|
|
|
Organisation code (planned cancer treatment type) |
|
|
|
ü |
|
|
Co-morbidity index |
|
|
|
ü |
|
|
Did the co-morbidity change the treatment the patient received? |
|
|
|
|
|
|
Lung clinical nurse specialist seen |
|
|
|
ü |
|
|
Date lung clinical nurse specialist first seen |
|
|
|
ü |
|
|
Section 6: Surgery | |||||
|
Surgical intent |
|
ü |
|
|
|
|
Date on which surgical procedure(s) carried out |
|
ü |
|
ü |
ü |
|
Surgical procedure(s) carried out |
|
ü |
|
ü |
ü |
|
Site code (of surgery) |
|
ü |
|
ü |
|
|
Section 7: Pathology | |||||
|
Date specimen taken |
|
ü |
|
|
|
|
Histological diagnosis |
|
ü |
|
ü |
ü |
|
Grade of differentiation |
|
ü |
|
|
|
|
T (Tumour) category (pathological) |
|
ü |
|
ü |
ü |
|
N (Node) category (pathological) |
|
ü |
|
ü |
ü |
|
M (Metastasis) category (pathological) |
|
ü |
|
ü |
ü |
|
Pathological stage grouping |
|
ü |
|
ü |
|
|
Excision margin(s) status |
|
|
|
ü |
|
|
Section 8: Drug Therapy | |||||
|
Date treatment started (drug therapy) |
|
ü |
|
ü |
ü |
|
Treatment intent (drug therapy) |
|
ü |
|
ü |
|
|
Drug therapy type |
|
ü |
|
|
|
|
Section 9: Radiotherapy | |||||
|
Date treatment started (radiotherapy) |
|
ü |
|
ü |
ü |
|
Treatment intent (radiotherapy) |
|
ü |
|
|
|
|
Radiotherapy type |
|
ü |
|
ü |
|
|
Anatomical treatment site (radiotherapy) |
|
|
|
ü |
|
|
Section 10: Palliative Care | |||||
|
Member of specialist palliative care team seen |
|
ü |
|
|
|
|
Section 11: Clinical Status Assessment | |||||
|
Date of death |
|
ü |
ü |
ü |
|
|
Complications / toxicity at clinical status assessment |
|
|
|
ü |
|
|
Section 12: AOF: Cancer Waiting Times | |||||
|
Priority of referral |
|
|
ü |
|
|
|
Date of decision to treat |
|
|
ü |
ü |
|
|
Date of start of first definitive procedure |
|
|
ü |
|
|
|
First procedure |
|
|
ü |
|
ü |
|
Suspension start date |
|
|
ü |
|
|
|
Suspension end date |
|
|
ü |
|
|
|
Reason for breach |
|
|
ü |
|
|
|
Section 13: Clinical Trials | |||||
|
Entry indicator |
|
ü |
|
ü |
ü |
|
Total number of data items: 73 | |||||